| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 14,746 | 41,255* | NaN | NaN |
| General and administrative | 10,753 | 8,291* | NaN | NaN |
| Total operating expenses | 25,499 | 49,546 | NaN | NaN |
| Loss from operations | -25,499 | -49,546* | NaN | NaN |
| Interest income | 1,319 | 1,584* | NaN | NaN |
| Other income, net | NaN | 65* | NaN | NaN |
| Other expense, net | -43 | NaN | NaN | NaN |
| Total other income, net | 1,276 | 1,649* | NaN | NaN |
| Loss before income taxes | -24,223 | -47,897 | NaN | NaN |
| Income tax benefit | 0 | NaN | NaN | NaN |
| Net loss | -24,223 | -47,897* | -18,040 | -15,993 |
| Adjustment of redeemable noncontrolling interest | NaN | -1,662* | 831 | NaN |
| Accretion of redeemable noncontrolling interest to redemption value | NaN | -13,352* | 2,828 | NaN |
| Deemed dividend on extinguishment of noncontrolling interest and redeemable noncontrolling interest | NaN | 9,101* | NaN | NaN |
| Net loss attributable to class a ordinary shareholders of zura | NaN | -45,308 | -20,037 | -15,993 |
| Basic EPS | -0.22 | -0.484 | -0.21 | -0.17 |
| Diluted EPS | -0.22 | -0.484 | -0.21 | -0.17 |
| Basic Average Shares | 112,222,789 | 93,625,828 | 94,564,632 | 94,289,954 |
| Diluted Average Shares | 112,222,789 | 93,625,828 | 94,564,632 | 94,289,954 |
Zura Bio Ltd (ZURA)
Zura Bio Ltd (ZURA)